A population-based study of the effectiveness of stereotactic ablative radiotherapy versus conventional fractionated radiotherapy for clinical stage I non-small cell lung cancer patients | ORKG Ask

We use cookies to provide a better user experience.

Data Protection

Related items

Stereotactic ablative radiotherapy versus lobectomy for operable stage I non-small-cell lung cancer:a pooled analysis of two randomised trials

Chang, Joe Y.
Senan, Suresh
Paul, Marinus A.
Mehran, Reza J.
Louie, Alexander V.
Balter, Peter
Groen, Harry
McRae, Stephen E.
Widder, Joachim
Feng, Lei
van den Borne, Ben E. E. M.
Munsell, Mark F.
Hurkmans, Coen
Berry, Donald A.
van Werkhoven, Erik
Kresl, John J.
Dingemans, Anne-Marie
Dawood, Omar
Haasbeek, Cornelis J. A.
Carpenter, Larry S.
De Jaeger, Katrien
Komaki, Ritsuko
Slotman, Ben J.
Smit, Egbert F.
Roth, Jack A.

June 2015

Background The standard of care for operable, stage I, non-small-cell lung cancer (NSCLC) is lobecto...

Stereotactic ablative radiotherapy versus lobectomy for operable stage I non-small-cell lung cancer:a pooled analysis of two randomised trials

Chang, Joe Y.
Senan, Suresh
Paul, Marinus A.
Mehran, Reza J.
Louie, Alexander V.
Balter, Peter
Groen, Harry
McRae, Stephen E.
Widder, Joachim
Feng, Lei
van den Borne, Ben E. E. M.
Munsell, Mark F.
Hurkmans, Coen
Berry, Donald A.
van Werkhoven, Erik
Kresl, John J.
Dingemans, Anne-Marie
Dawood, Omar
Haasbeek, Cornelis J. A.
Carpenter, Larry S.
De Jaeger, Katrien
Komaki, Ritsuko
Slotman, Ben J.
Smit, Egbert F.
Roth, Jack A.

June 2015

Background The standard of care for operable, stage I, non-small-cell lung cancer (NSCLC) is lobecto...

Stereotactic ablative radiotherapy versus lobectomy for operable stage I non-small-cell lung cancer:a pooled analysis of two randomised trials

Chang, Joe Y.
Senan, Suresh
Paul, Marinus A.
Mehran, Reza J.
Louie, Alexander V.
Balter, Peter
Groen, Harry
McRae, Stephen E.
Widder, Joachim
Feng, Lei
van den Borne, Ben E. E. M.
Munsell, Mark F.
Hurkmans, Coen
Berry, Donald A.
van Werkhoven, Erik
Kresl, John J.
Dingemans, Anne-Marie
Dawood, Omar
Haasbeek, Cornelis J. A.
Carpenter, Larry S.
De Jaeger, Katrien
Komaki, Ritsuko
Slotman, Ben J.
Smit, Egbert F.
Roth, Jack A.

June 2015

Background The standard of care for operable, stage I, non-small-cell lung cancer (NSCLC) is lobecto...

Are three doses of stereotactic ablative radiotherapy (SABR) more effective than 30 doses of conventional radiotherapy?

Simeonova A. O.
Fleckenstein K.
Wertz H.
Frauenfeld A.
Boda-Heggemann J.
Lohr F.
Wenz F.

January 2012

In early stage non-small cell lung cancer (NSCLC) definitive radiation therapy is an appropriate alt...

Are three doses of stereotactic ablative radiotherapy (SABR) more effective than 30 doses of conventional radiotherapy?

Simeonova A. O.
Fleckenstein K.
Wertz H.
Frauenfeld A.
Boda-Heggemann J.
Lohr F.
Wenz F.

January 2012

In early stage non-small cell lung cancer (NSCLC) definitive radiation therapy is an appropriate alt...

Treatment of Early Stage Non-Small Cell Lung Cancer: Surgery or Stereotactic Ablative Radiotherapy?

Esengül Koçak Uzel
Ufuk Abacıoğlu

March 2015

The management of early-stage Non-small Cell Lung Cancer (NSCLC) has improved recently due to advanc...

Stereotactic ablative radiotherapy versus standard radiotherapy in stage 1 non-small-cell lung cancer (TROG 09.02 CHISEL): a phase 3, open-label, randomised controlled trial

Ball, David
Mai, G. Tao
Vinod, Shalini
Babington, Scott
Ruben, Jeremy
Kron, Tomas
Chesson, Brent
Herschtal, Alan
Vanevski, Marijana
Rezo, Angela
Elder, Christine
Skala, Marketa
Wirth, Andrew
Wheeler, Greg
Lim, Adeline
Shaw, Mark
Schofield, Penelope
Irving, Louis
Solomon, Benjamin
on behalf of the TROG 09.02 CHISEL investigators
Nedev, Nick
Le, Hien

April 2019

Background: Stereotactic ablative body radiotherapy (SABR) is widely used to treat inoperable stage ...

Stereotactic ablative radiotherapy versus lobectomy for operable stage I non-small-cell lung cancer: a pooled analysis of two randomised trials

Chang, Joe Y.
Senan, Suresh
Paul, Marinus A.
Mehran, Reza J.
Louie, Alexander V.
Balter, Peter
Groen, Harry J. M.
McRae, Stephen E.
Widder, Joachim
Feng, Lei
van den Borne, Ben E. E. M.
Munsell, Mark F.
Hurkmans, Coen
Berry, Donald A.
van Werkhoven, Erik
Kresl, John J.
Dingemans, Anne-Marie
Dawood, Omar
Haasbeek, Cornelis J. A.
Carpenter, Larry S.
De Jaeger, Katrien
Komaki, Ritsuko
Slotman, Ben J.
Smit, Egbert F.
Roth, Jack A.

June 2015

Background The standard of care for operable, stage I, non-small-cell lung cancer (NSCLC) is lobecto...

Stereotactic ablative radiotherapy versus lobectomy for operable stage I non-small-cell lung cancer: a pooled analysis of two randomised trials

Chang, Joe Y.
Senan, Suresh
Paul, Marinus A.
Mehran, Reza J.
Louie, Alexander V.
Balter, Peter
Groen, Harry
McRae, Stephen E.
Widder, Joachim
Feng, Lei
van den Borne, Ben E. E. M.
Munsell, Mark F.
Hurkmans, Coen
Berry, Donald A.
van Werkhoven, Erik
Kresl, John J.
Dingemans, Anne-Marie
Dawood, Omar
Haasbeek, Cornelis J. A.
Carpenter, Larry S.
De Jaeger, Katrien
Komaki, Ritsuko
Slotman, Ben J.
Smit, Egbert F.
Roth, Jack A.

June 2015

Background The standard of care for operable, stage I, non-small-cell lung cancer (NSCLC) is lobecto...

Stereotactic ablative radiotherapy versus lobectomy for operable stage I non-small-cell lung cancer:a pooled analysis of two randomised trials

Chang, Joe Y.
Senan, Suresh
Paul, Marinus A.
Mehran, Reza J.
Louie, Alexander V.
Balter, Peter
Groen, Harry
McRae, Stephen E.
Widder, Joachim
Feng, Lei
van den Borne, Ben E. E. M.
Munsell, Mark F.
Hurkmans, Coen
Berry, Donald A.
van Werkhoven, Erik
Kresl, John J.
Dingemans, Anne-Marie
Dawood, Omar
Haasbeek, Cornelis J. A.
Carpenter, Larry S.
De Jaeger, Katrien
Komaki, Ritsuko
Slotman, Ben J.
Smit, Egbert F.
Roth, Jack A.

June 2015

Background The standard of care for operable, stage I, non-small-cell lung cancer (NSCLC) is lobecto...

Stereotactic ablative radiotherapy versus lobectomy for operable stage I non-small-cell lung cancer:a pooled analysis of two randomised trials

Chang, Joe Y.
Senan, Suresh
Paul, Marinus A.
Mehran, Reza J.
Louie, Alexander V.
Balter, Peter
Groen, Harry
McRae, Stephen E.
Widder, Joachim
Feng, Lei
van den Borne, Ben E. E. M.
Munsell, Mark F.
Hurkmans, Coen
Berry, Donald A.
van Werkhoven, Erik
Kresl, John J.
Dingemans, Anne-Marie
Dawood, Omar
Haasbeek, Cornelis J. A.
Carpenter, Larry S.
De Jaeger, Katrien
Komaki, Ritsuko
Slotman, Ben J.
Smit, Egbert F.
Roth, Jack A.

June 2015

Background The standard of care for operable, stage I, non-small-cell lung cancer (NSCLC) is lobecto...

Stereotactic ablative radiotherapy versus lobectomy for operable stage I non-small-cell lung cancer:a pooled analysis of two randomised trials

Chang, Joe Y.
Senan, Suresh
Paul, Marinus A.
Mehran, Reza J.
Louie, Alexander V.
Balter, Peter
Groen, Harry
McRae, Stephen E.
Widder, Joachim
Feng, Lei
van den Borne, Ben E. E. M.
Munsell, Mark F.
Hurkmans, Coen
Berry, Donald A.
van Werkhoven, Erik
Kresl, John J.
Dingemans, Anne-Marie
Dawood, Omar
Haasbeek, Cornelis J. A.
Carpenter, Larry S.
De Jaeger, Katrien
Komaki, Ritsuko
Slotman, Ben J.
Smit, Egbert F.
Roth, Jack A.

June 2015

Background The standard of care for operable, stage I, non-small-cell lung cancer (NSCLC) is lobecto...

Stereotactic ablative radiotherapy versus lobectomy for operable stage I non-small-cell lung cancer:a pooled analysis of two randomised trials

Chang, Joe Y.
Senan, Suresh
Paul, Marinus A.
Mehran, Reza J.
Louie, Alexander V.
Balter, Peter
Groen, Harry
McRae, Stephen E.
Widder, Joachim
Feng, Lei
van den Borne, Ben E. E. M.
Munsell, Mark F.
Hurkmans, Coen
Berry, Donald A.
van Werkhoven, Erik
Kresl, John J.
Dingemans, Anne-Marie
Dawood, Omar
Haasbeek, Cornelis J. A.
Carpenter, Larry S.
De Jaeger, Katrien
Komaki, Ritsuko
Slotman, Ben J.
Smit, Egbert F.
Roth, Jack A.

June 2015

Background The standard of care for operable, stage I, non-small-cell lung cancer (NSCLC) is lobecto...

Stereotactic ablative radiotherapy versus lobectomy for operable stage I non-small-cell lung cancer:a pooled analysis of two randomised trials

Chang, Joe Y.
Senan, Suresh
Paul, Marinus A.
Mehran, Reza J.
Louie, Alexander V.
Balter, Peter
Groen, Harry
McRae, Stephen E.
Widder, Joachim
Feng, Lei
van den Borne, Ben E. E. M.
Munsell, Mark F.
Hurkmans, Coen
Berry, Donald A.
van Werkhoven, Erik
Kresl, John J.
Dingemans, Anne-Marie
Dawood, Omar
Haasbeek, Cornelis J. A.
Carpenter, Larry S.
De Jaeger, Katrien
Komaki, Ritsuko
Slotman, Ben J.
Smit, Egbert F.
Roth, Jack A.

June 2015

Background The standard of care for operable, stage I, non-small-cell lung cancer (NSCLC) is lobecto...

Stereotactic ablative radiotherapy versus standard radiotherapy in stage 1 non-small-cell lung cancer (TROG 09.02 CHISEL): a phase 3, open-label, randomised controlled trial

Ball, David
Mai, G. Tao
Vinod, Shalini
Babington, Scott
Ruben, Jeremy
Kron, Tomas
Chesson, Brent
Herschtal, Alan
Vanevski, Marijana
Rezo, Angela
Elder, Christine
Skala, Marketa
Wirth, Andrew
Wheeler, Greg
Lim, Adeline
Shaw, Mark
Schofield, Penelope
Irving, Louis
Solomon, Benjamin
on behalf of the TROG 09.02 CHISEL investigators
Nedev, Nick
Le, Hien

April 2019

Background: Stereotactic ablative body radiotherapy (SABR) is widely used to treat inoperable stage ...

Stereotactic ablative radiotherapy versus lobectomy for operable stage I non-small-cell lung cancer: a pooled analysis of two randomised trials

Chang, Joe Y.
Senan, Suresh
Paul, Marinus A.
Mehran, Reza J.
Louie, Alexander V.
Balter, Peter
Groen, Harry J. M.
McRae, Stephen E.
Widder, Joachim
Feng, Lei
van den Borne, Ben E. E. M.
Munsell, Mark F.
Hurkmans, Coen
Berry, Donald A.
van Werkhoven, Erik
Kresl, John J.
Dingemans, Anne-Marie
Dawood, Omar
Haasbeek, Cornelis J. A.
Carpenter, Larry S.
De Jaeger, Katrien
Komaki, Ritsuko
Slotman, Ben J.
Smit, Egbert F.
Roth, Jack A.

June 2015

Background The standard of care for operable, stage I, non-small-cell lung cancer (NSCLC) is lobecto...

Stereotactic ablative radiotherapy versus lobectomy for operable stage I non-small-cell lung cancer: a pooled analysis of two randomised trials

Chang, Joe Y.
Senan, Suresh
Paul, Marinus A.
Mehran, Reza J.
Louie, Alexander V.
Balter, Peter
Groen, Harry
McRae, Stephen E.
Widder, Joachim
Feng, Lei
van den Borne, Ben E. E. M.
Munsell, Mark F.
Hurkmans, Coen
Berry, Donald A.
van Werkhoven, Erik
Kresl, John J.
Dingemans, Anne-Marie
Dawood, Omar
Haasbeek, Cornelis J. A.
Carpenter, Larry S.
De Jaeger, Katrien
Komaki, Ritsuko
Slotman, Ben J.
Smit, Egbert F.
Roth, Jack A.

June 2015

Background The standard of care for operable, stage I, non-small-cell lung cancer (NSCLC) is lobecto...

Stereotactic ablative radiotherapy versus lobectomy for operable stage I non-small-cell lung cancer:a pooled analysis of two randomised trials

Chang, Joe Y.
Senan, Suresh
Paul, Marinus A.
Mehran, Reza J.
Louie, Alexander V.
Balter, Peter
Groen, Harry
McRae, Stephen E.
Widder, Joachim
Feng, Lei
van den Borne, Ben E. E. M.
Munsell, Mark F.
Hurkmans, Coen
Berry, Donald A.
van Werkhoven, Erik
Kresl, John J.
Dingemans, Anne-Marie
Dawood, Omar
Haasbeek, Cornelis J. A.
Carpenter, Larry S.
De Jaeger, Katrien
Komaki, Ritsuko
Slotman, Ben J.
Smit, Egbert F.
Roth, Jack A.

June 2015

Background The standard of care for operable, stage I, non-small-cell lung cancer (NSCLC) is lobecto...

Stereotactic ablative radiotherapy versus lobectomy for operable stage I non-small-cell lung cancer:a pooled analysis of two randomised trials

Chang, Joe Y.
Senan, Suresh
Paul, Marinus A.
Mehran, Reza J.
Louie, Alexander V.
Balter, Peter
Groen, Harry
McRae, Stephen E.
Widder, Joachim
Feng, Lei
van den Borne, Ben E. E. M.
Munsell, Mark F.
Hurkmans, Coen
Berry, Donald A.
van Werkhoven, Erik
Kresl, John J.
Dingemans, Anne-Marie
Dawood, Omar
Haasbeek, Cornelis J. A.
Carpenter, Larry S.
De Jaeger, Katrien
Komaki, Ritsuko
Slotman, Ben J.
Smit, Egbert F.
Roth, Jack A.

June 2015

Background The standard of care for operable, stage I, non-small-cell lung cancer (NSCLC) is lobecto...

Stereotactic ablative radiotherapy versus lobectomy for operable stage I non-small-cell lung cancer:a pooled analysis of two randomised trials

Chang, Joe Y.
Senan, Suresh
Paul, Marinus A.
Mehran, Reza J.
Louie, Alexander V.
Balter, Peter
Groen, Harry
McRae, Stephen E.
Widder, Joachim
Feng, Lei
van den Borne, Ben E. E. M.
Munsell, Mark F.
Hurkmans, Coen
Berry, Donald A.
van Werkhoven, Erik
Kresl, John J.
Dingemans, Anne-Marie
Dawood, Omar
Haasbeek, Cornelis J. A.
Carpenter, Larry S.
De Jaeger, Katrien
Komaki, Ritsuko
Slotman, Ben J.
Smit, Egbert F.
Roth, Jack A.

June 2015

Background The standard of care for operable, stage I, non-small-cell lung cancer (NSCLC) is lobecto...

Stereotactic ablative radiotherapy versus lobectomy for operable stage I non-small-cell lung cancer:a pooled analysis of two randomised trials

Chang, Joe Y.
Senan, Suresh
Paul, Marinus A.
Mehran, Reza J.
Louie, Alexander V.
Balter, Peter
Groen, Harry
McRae, Stephen E.
Widder, Joachim
Feng, Lei
van den Borne, Ben E. E. M.
Munsell, Mark F.
Hurkmans, Coen
Berry, Donald A.
van Werkhoven, Erik
Kresl, John J.
Dingemans, Anne-Marie
Dawood, Omar
Haasbeek, Cornelis J. A.
Carpenter, Larry S.
De Jaeger, Katrien
Komaki, Ritsuko
Slotman, Ben J.
Smit, Egbert F.
Roth, Jack A.

June 2015

Background The standard of care for operable, stage I, non-small-cell lung cancer (NSCLC) is lobecto...

Stereotactic ablative radiotherapy versus lobectomy for operable stage I non-small-cell lung cancer:a pooled analysis of two randomised trials

Chang, Joe Y.
Senan, Suresh
Paul, Marinus A.
Mehran, Reza J.
Louie, Alexander V.
Balter, Peter
Groen, Harry
McRae, Stephen E.
Widder, Joachim
Feng, Lei
van den Borne, Ben E. E. M.
Munsell, Mark F.
Hurkmans, Coen
Berry, Donald A.
van Werkhoven, Erik
Kresl, John J.
Dingemans, Anne-Marie
Dawood, Omar
Haasbeek, Cornelis J. A.
Carpenter, Larry S.
De Jaeger, Katrien
Komaki, Ritsuko
Slotman, Ben J.
Smit, Egbert F.
Roth, Jack A.

June 2015

Background The standard of care for operable, stage I, non-small-cell lung cancer (NSCLC) is lobecto...